INS and Insulin resistance: Considering a substantial proportion of the study population had established T2DM and had been receiving medications that may confound both insulin secretion and insulin sensitivity mechanisms, we find it more feasible not to include HOMA-IR, the most frequently used marker for insulin resistance in clinical practice, in the analysis, although it was available in some of the patients.